Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

Establishing national reference materials for genetic testing of cytochrome P450

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project

Systematic Screening for Polymorphisms in the CYP3A4 Gene in the Chinese Population.

Establishment of genomic RNA reference materials for BCR-ABL1 P210 measurement

Development of a New Genetic Reference Material System Based on Saccharomyces Cerevisiae Cells

Quality Control of Next-generation Sequencing-based in Vitro Diagnostic Test for Onco-relevant Mutations Using Multiplex Reference Materials in Plasma

Construction of a Reference Material Panel for Detecting KRAS/NRAS/EGFR/BRAF/MET Mutations in Plasma Ctdna

A Systematically Combined Genotype And Functional Combination Analysis Of Cyp2e1, Cyp2d6, Cyp2c9, Cyp2c19 In Different Geographic Areas Of Mainland China - A Basis For Personalized Therapy

An Oligonucleotide Microarray for Detection of Cytochrome P450 Enzyme Gene Polymorphisms Related to Paclitaxel Metabolism

Establishment and application of a real-time loop-mediated isothermal amplification system for the detection of CYP2C19 polymorphisms

Development of a nine-variant reference material panel to standardize cell-free DNA detection

Development of preimplantation genetic testing for monogenic reference materials using next-generation sequencing

Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population

Harmonization of distributed multi‐center analysis based on dried blood spot reference materials supporting the screening of neonatal inherited metabolic disorders

Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

Reference materials for molecular diagnostics: Current achievements and future strategies

Identification and Functional Assessment of Eight CYP3A4 Allelic Variants 39-46 Detected in the Chinese Han Population

Clinical application and importance of one-step human CYP2C19 genotype detection

Reference Standards for Newborn Screening of Metabolic Disorders by Tandem Mass Spectrometry: A Nationwide Study on Millions of Chinese Neonatal Populations

[Analysis of Glucocorticoid Receptor Gene Polymorphisms by Denaturing High-Performance Liquid Chromatography].